跳至主要内容
临床试验/NCT05095896
NCT05095896已完成不适用

The Serum Lipid Profiles in Immune Thrombocytopenia: a Retrospective Study

Ming Hou1 个研究点 分布在 1 个国家目标入组 457 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
457
试验地点
1
主要终点
Platelet count at 1 month after initial therapy

研究概览

简要总结

The project was retrospectively undertaking by Qilu Hospital of Shandong University in China. In order to investigate the correlations between platelet indices, serum lipids and bleeding symptoms in ITP.

详细描述

Background: Immune thrombocytopenia (ITP) is an autoimmune hemorrhagic disease characterized by increased platelet destruction and impaired thrombopoiesis. Platelet indices changes depending on the morphology and volume of platelets. Serum lipids have been found to affect platelet formation and activity in certain diseases, thus induce the corresponding variation of platelet indices.

Objectives: To investigate the correlations between platelet indices, serum lipids and bleeding symptoms in ITP.

Methods: The clinical data from 457 ITP patients were retrospectively collected and analyzed, including platelet indices, serum lipids, hemorrhage and therapeutic regimen.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet the diagnostic criteria for immune thrombocytopenia.

排除标准

  • (1) receiving platelet transfusion within 7 days or ITP-related medication within 3 months (2) treated with lipid-lowing agents, including statins, fibrates, niacin, bile sequestrant resins, ezetimibe and so on.

结局指标

主要结局

Platelet count at 1 month after initial therapy

时间窗: 1 month

Platelet count was tested at 1 month after initial therapy

次要结局

未报告次要终点

研究者

发起方
Ming Hou
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ming Hou

Manager

Shandong University

研究点 (1)

Loading locations...

相似试验